Epidemiology of human pulmonary infection with nontuberculous mycobacteria a review

Clinics in Chest Medicine

Volumn 36, Issue 1, 2015, Pages 13-34

  Prevots, D Rebecca ^a   Marras, Theodore K ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Epidemiology; Global; Nontuberculous mycobacteria; Pulmonary disease

Indexed keywords

AFRICA; ARTICLE; ASIA; ATYPICAL MYCOBACTERIOSIS; AUSTRALIA; BACTERIUM ISOLATION; CENTRAL AMERICA; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; EAST ASIA; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; EPIDEMIOLOGICAL MONITORING; EUROPE; HIGH RISK POPULATION; HOST SUSCEPTIBILITY; HUMAN; INCIDENCE; LUNG INFECTION; MIDDLE EAST; NEW ZEALAND; NORTH AMERICA; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SOUTH AMERICA; SOUTH ASIA; ATYPICAL MYCOBACTERIUM; HEALTH; LUNG DISEASES; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PATHOGENICITY;

GLOBAL HEALTH; HUMANS; LUNG DISEASES; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PREVALENCE;

EID: 84922389432     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2014.10.002     Document Type: Review

References (88)

1. Marras T.K., Daley C.L. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002, 23:553-567.
2. Thomson R.M., NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010, 16:1576-1583.
3. Prevots D.R., Shaw P.A., Strickland D., et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010, 182:970-976.
4. Winthrop K.L., McNelley E., Kendall B., et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010, 182:977-982.
5. Andrejak C., Thomsen V.O., Johansen I.S., et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010, 181:514-521.
6. Griffith D.E., Aksamit T., Brown-Elliott B.A., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
7. Adjemian J., Olivier K.N., Seitz A.E., et al. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 2012, 185:881-886.
8. Marras T.K., Mendelson D., Marchand-Austin A., et al. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis 2013, 19:1889-1891.
9. Mirsaeidi M., Machado R.F., Garcia J.G., et al. Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study. PLoS One 2014, 9:e91879.
10. Morimoto K., Iwai K., Uchimura K., et al. Asteady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann Am Thorac Soc 2014, 11:1-8.
11. Colombo R.E., Hill S.C., Claypool R.J., et al. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest 2010, 137:629-634.
12. Leung J.M., Fowler C., Smith C., et al. Afamilial syndrome of pulmonary nontuberculous mycobacteria infections. Am J Respir Crit Care Med 2013, 188:1373-1376.
13. Cutting G.R. Modifier genes in mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci 2010, 1214:57-69.
14. Kubo K., Yamazaki Y., Hanaoka M., et al. Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection. Am J Respir Crit Care Med 2000, 161:1368-1371.
15. Takahashi M., Ishizaka A., Nakamura H., et al. Specific HLA in pulmonary MAC infection in a Japanese population. Am J Respir Crit Care Med 2000, 162:316-318.
16. Feazel L.M., Baumgartner L.K., Peterson K.L., et al. Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci U S A 2009, 106:16393-16399.
17. Adjemian J., Olivier K.N., Seitz A.E., et al. Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med 2012, 186:553-558.
18. Chou M.P., Clements A.C., Thomson R.M. Aspatial epidemiological analysis of nontuberculous mycobacterial infections in Queensland, Australia. BMC Infect Dis 2014, 14:279.
19. Dirac M.A., Horan K.L., Doody D.R., et al. Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012, 186:684-691.
20. Prevots D.R., Adjemian J., Fernandez A.G., et al. Environmental risks for nontuberculous mycobacteria: individual exposures and climatic factors in the cystic fibrosis population. Ann Am Thorac Soc 2014, 11:1032-1038.
21. Maekawa K., Ito Y., Hirai T., et al. Environmental risk factors for pulmonary mycobacterium avium-intracellulare complex disease. Chest 2011, 140:723-729.
22. Olivier K.N., Weber D.J., Wallace R.J., et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003, 167:828-834.
23. Andrejak C., Nielsen R., Thomsen V.O., et al. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax 2013, 68:256-262.
24. Prince D.S., Peterson D.D., Steiner R.M., et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. NEngl J Med 1989, 321:863-868.
25. Kim R.D., Greenberg D.E., Ehrmantraut M.E., et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008, 178:1066-1074.
26. Brode S.K., Jamieson F.B., Ng R., et al. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest 2014, 146:563-572.
27. Winthrop K.L., Baxter R., Liu L., et al. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis 2013, 72:37-42.
28. Adjemian J., Olivier K.N., Prevots D.R. Nontuberculous mycobacteria among cystic fibrosis patients in the United States: screening practices and environmental risk. Am J Respir Crit Care Med 2014, 190:581-586.
29. Edwards L.B., Acquaviva F.A., Livesay V.T., et al. Clinical and laboratory studies of tuberculosis and respiratory disease: the Navy Recruit Program. Am Rev Respir Dis 1969, 99:1-132.
30. Kirschner R.A., Parker B.C., Falkinham J.O. Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. Am Rev Respir Dis 1992, 145:271-275.
31. Maugein J., Dailloux M., Carbonelle B., et al. Sentinel site surveillance of Mycobacterium avium complex pulmonary disease. Eur Respir J 2005, 26:1092-1096.
32. Winthrop K.L., Baxter R., Liu L., et al. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf 2011, 20:229-235.
33. Hoefsloot W., van Ingen J., Andrejak C., et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 2013, 42:1604-1613.
34. Cassidy P.M., Hedberg K., Saulson A., et al. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009, 49:e124-e129.
35. Marras T.K., Chedore P., Ying A.M., et al. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario 1997-2003. Thorax 2007, 62:661-666.
36. Al-Houqani M., Jamieson F., Chedore P., et al. Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007. Can Respir J 2011, 18:19-24.
37. Marras T.K., Mehta M., Chedore P., et al. Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung 2010, 188:289-299.
38. Satyanarayana G., Heysell S.K., Scully K.W., et al. Mycobacterial infections in a large Virginia hospital, 2001-2009. BMC Infect Dis 2011, 11:113.
39. Zamarioli L.A., Coelho A.G., Pereira C.M., et al. Descriptive study of the frequency of nontuberculous mycobacteria in the Baixada Santista region of the state of Sao Paulo, Brazil. JBras Pneumol 2008, 34:590-594.
40. Pedro H.S., Pereira M.I., Goloni M.R., et al. Nontuberculous mycobacteria isolated in Sao Jose do Rio Preto, Brazil between 1996 and 2005. JBras Pneumol 2008, 34:950-955.
41. Imperiale B., Zumarraga M., Gioffre A., et al. Disease caused by non-tuberculous mycobacteria: diagnostic procedures and treatment evaluation in the north of Buenos Aires Province. Rev Argent Microbiol 2012, 44:3-9.
42. de Mello K.G., Mello F.C., Borga L., et al. Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011. Emerg Infect Dis 2013, 19:393-399.
43. Fusco da Costa A.R., Falkinham J.O., Lopes M.L., et al. Occurrence of nontuberculous mycobacterial pulmonary infection in an endemic area of tuberculosis. PLoS Negl Trop Dis 2013, 7:e2340. [Electronic resource].
44. Kennedy M.P., O'Connor T.M., Ryan C., et al. Nontuberculous mycobacteria: incidence in Southwest Ireland from 1987 to 2000. Respir Med 2003, 97:257-263.
45. Dailloux M., Abalain M.L., Laurain C., et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006, 28:1211-1215.
46. Henry M.T., Inamdar L., O'Riordain D., et al. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 2004, 23:741-746.
47. Gerogianni I., Papala M., Kostikas K., et al. Epidemiology and clinical significance of mycobacterial respiratory infections in Central Greece. Int J Tuberc Lung Dis 2008, 12:807-812.
48. Van Ingen J., Bendien S.A., de Lange W.C., et al. Clinical relevance of nontuberculous mycobacteria isolated in Nijmegen-Arnhem region, The Netherlands. Thorax 2009, 64:502-506.
49. Gitti Z., Mantadakis E., Maraki S., et al. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece. Future Microbiol 2011, 6:1099-1109.
50. McCallum A.D., Watkin S.W., Faccenda J.F. Non-tuberculous mycobacterial infections in the Scottish Borders: identification, management and treatment outcomes-a retrospective review. JR Coll Physicians Edinb 2011, 41:294-303.
51. Jankovic M., Samarzija M., Sabol I., et al. Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia. Int J Tuberc Lung Dis 2013, 17:836-841.
52. Marusic A., Katalinic-Jankovic V., Popovic-Grle S., et al. Mycobacterium xenopi pulmonary disease-epidemiology and clinical features in non-immunocompromised patients. JInfect 2009, 58:108-112.
53. van Ingen J., Hoefsloot W., Dekhuijzen P.N., et al. The changing pattern of clinical Mycobacterium avium isolation in the Netherlands. Int J Tuberc Lung Dis 2010, 14:1176-1180.
54. OECD OECD factbook 2014: economic, environmental and social statistics 2014, OECD Publishing, Available at:, Accesssed October 29, 2014. http://www.oecd-ilibrary.org/economics/oecd-factbook-2014_factbook-2014-en.
55. Nyamogoba H.D., Mbuthia G., Mining S., et al. HIV co-infection with tuberculous and non-tuberculous mycobacteria in western Kenya: challenges in the diagnosis and management. Afr Health Sci 2012, 12:305-311.
56. Aliyu G., El-Kamary S.S., Abimiku A., et al. Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria. PLoS One 2013, 8:e63170. [Electronic resource].
57. Asiimwe B.B., Bagyenzi G.B., Ssengooba W., et al. Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda. BMC Infect Dis 2013, 13:88.
58. Badoum G., Saleri N., Dembele M.S., et al. Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?. Eur Respir J 2011, 37:1283-1285.
59. Maiga M., Siddiqui S., Diallo S., et al. Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis. PLoS One 2012, 7:e36902. [Electronic resource].
60. Bicmen C., Coskun M., Gunduz A.T., et al. Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not?. New Microbiol 2010, 33:399-403.
61. Braun E., Sprecher H., Davidson S., et al. Epidemiology and clinical significance of non-tuberculous mycobacteria isolated from pulmonary specimens. Int J Tuberc Lung Dis 2012, 17:96-99.
62. Varghese B., Memish Z., Abuljadayel N., et al. Emergence of clinically relevant non-tuberculous mycobacterial infections in Saudi Arabia. PLoS Negl Trop Dis 2013, 7:e2234. [Electronic resource].
63. Al-Mahruqi S.H., van-Ingen J., Al-Busaidy S., et al. Clinical relevance of nontuberculous mycobacteria, Oman. Emerg Infect Dis 2009, 15:292-294.
64. Shenai S., Rodrigues C., Mehta A. Time to identify and define non-tuberculous mycobacteria in a tuberculosis-endemic region. Int J Tuberc Lung Dis 2010, 14:1001-1008.
65. Koh W.J., Kwon O.J., Jeon K., et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006, 129:341-348.
66. American Thoracic Society Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997, 156:S1-S25.
67. British Thoracic Society Management of opportunist mycobacterial infections: Joint tuberculosis committee guidelines 1999. Thorax 2000, 55:210-218.
68. Okumura M., Iwai K., Ogata H., et al. Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 2008, 47:1465-1472.
69. Hayashi M., Takayanagi N., Kanauchi T., et al. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012, 185:575-583.
70. Ito Y., Hirai T., Maekawa K., et al. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis 2012, 16:408-414.
71. Wang C.C., Lin M.C., Liu J.W., et al. Nontuberculous mycobacterial lung disease in southern Taiwan. Chang Gung Med J 2009, 32:499-508.
72. Lai C.C., Tan C.K., Chou C.H., et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis 2010, 16:294-296.
73. Shu C.C., Lee C.H., Hsu C.L., et al. Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns. Lung 2011, 189:467-474.
74. Wang H.X., Yue J., Han M., et al. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008. Chin Med J 2010, 123:184-187.
75. Jing H., Wang H., Wang Y., et al. Prevalence of nontuberculous mycobacteria infection, China, 2004-2009. Emerg Infect Dis 2012, 18:527-528.
76. Haverkort F. National atypical mycobacteria survey, 2000. Commun Dis Intell Q Rep 2003, 27:180-189.
77. Freeman J., Morris A., Blackmore T., et al. Incidence of nontuberculous mycobacterial disease in New Zealand, 2004. NZ Med J 2007, 120:U2580.
78. Brode S.K., Jamieson F.B., Ng R., et al. Population-based risk of mycobacterial infections associated with anti-tumor necrosis factor (anti-TNF) therapy in older patients in Ontario, Canada. Chest 2013, 144(4_MeetingAbstracts):270A. 10.1378/chest.1704023.
79. Bodle E.E., Cunnigham J.A., Della-Latta, et al. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis 2008, 14:390-396.
80. Amorim A., Macedo R., Lopes A., et al. Non-tuberculous mycobacteria in HIV-negative patients with pulmonary disease in Lisbon, Portugal. Scand J Infect Dis 2010, 42:626-628.
81. Del Giudice G., Iadevaia C., Santoro G., et al. Nontuberculous mycobacterial lung disease in patients without HIV infection: a retrospective analysis over 3 years. Clin Respir J 2011, 5:203-210.
82. Davies B.S., Roberts C.H., Kaul S., et al. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London. Scand J Infect Dis 2012, 44:815-819.
83. Park Y.S., Lee C.H., Lee S.M., et al. Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis 2010, 14:1069-1071.
84. Lee S.K., Lee E.J., Kim S.K., et al. Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea. Scand J Infect Dis 2012, 44:733-738.
85. Al-Houqani M., Jamieson F., Mehta M., et al. Aging, COPD and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario. Chest 2012, 141:190-197.
86. van Ingen J., Boeree M.J., de Lange W.C., et al. Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis 2008, 14:385-389.
87. van Ingen J., de Zwaan R., Dekhuijzen R.P., et al. Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. JInfect 2009, 59:324-331.
88. Hoefsloot W., van Ingen J., de Lange W.C., et al. Clinical relevance of Mycobacterium malmoense isolation in The Netherlands. Eur Respir J 2009, 34:926-931.